Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics

por Stoehr, R, Hitzenbichler, F, Kneitz, B, Hammerschmied, C G, Burger, M, Tannapfel, A, Hartmann, A
Publicado 2008